Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (NDUFV1) is a core subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase), the first and largest enzyme complex of the mitochondrial respiratory chain. Located in the mitochondrial inner membrane, NDUFV1 contains the binding sites for NADH, flavin mononucleotide (FMN), and a [4Fe-4S] iron-sulfur cluster, making it essential for initiating electron transfer from NADH to the respiratory chain. Mutations in the NDUFV1 gene are a primary cause of autosomal recessive mitochondrial complex I deficiency, which manifests as severe neurodegenerative and metabolic disorders such as Leigh syndrome, leukodystrophy, and infantile bilateral striatal necrosis. In oncology, NDUFV1 and complex I are targeted by small-molecule inhibitors like IACS-010759 and ME-344 to disrupt oxidative phosphorylation (OXPHOS) in cancer cells that are highly dependent on mitochondrial respiration. Additionally, first-line antidiabetic drugs like metformin and natural compounds like magnolol modulate NDUFV1 activity to regulate cellular energy homeostasis and lipid metabolism. However, therapeutic targeting of NDUFV1 carries significant safety risks, including severe neurotoxicity, lactic acidosis, and mitochondrial dysfunction, mimicking the phenotypes of genetic complex I deficiency.
Inhibition of mitochondrial complex I activity, which blocks the oxidation of NADH to NAD+, disrupts the electron transport chain, reduces ATP synthesis, and increases the production of reactive oxygen species (ROS).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (NDUFV1) (NDUFV1).